Desq Long
Sign in

Company

Century Therapeutics, Inc.

IPSC · CIK 0001850119

SEC FORM 4
$3,199.94

Century Therapeutics, Inc. (IPSC)

Sale of 1,658 shares at $1.93 per share.

Reporting Person Carr Douglas · Officer Title SVP Finance & Operations · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001867173-26-000020 · filed 2026-09-15 · View filing →

SEC FORM 4
$4,992.91

Century Therapeutics, Inc. (IPSC)

Sale of 2,587 shares at $1.93 per share.

Reporting Person Russotti Gregory · Officer Title See Remarks · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001867305-26-000014 · filed 2026-09-15 · View filing →

SEC FORM 4
$26,869.00

Century Therapeutics, Inc. (IPSC)

Disposition (code F) of 13,850 shares at $1.94 per share.

Reporting Person Pfeiffenberger Brent · Officer Title President and CEO · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0002001162-26-000018 · filed 2026-09-15 · View filing →

SEC FORM 4
$520.70

Century Therapeutics, Inc. (IPSC)

Sale of 254 shares at $2.05 per share.

Reporting Person Carr Douglas · Officer Title SVP Finance & Operations · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001867173-26-000018 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,094.70

Century Therapeutics, Inc. (IPSC)

Sale of 534 shares at $2.05 per share.

Reporting Person Russotti Gregory · Officer Title See Remarks · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001867305-26-000012 · filed 2026-09-09 · View filing →

SEC FORM 4
$976.93

Century Therapeutics, Inc. (IPSC)

Disposition (code F) of 463 shares at $2.11 per share.

Reporting Person Pfeiffenberger Brent · Officer Title President and CEO · Transaction Code F

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0002001162-26-000016 · filed 2026-09-09 · View filing →

SEC FORM 4
$59,850.24

Century Therapeutics, Inc. (IPSC)

Disposition (code F) of 31,172 shares at $1.92 per share.

Reporting Person Pfeiffenberger Brent · Officer Title President and CEO · Transaction Code F

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0002001162-26-000014 · filed 2026-08-18 · View filing →